A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
A novel dry powder inhaler device will be used to administer mannitol to healthy subjects and
subjects with bronchiectasis in single doses higher than previously given.The main objective
is to assess tolerability of these doses using the new device.